Movement Disorders

October 2022, Volume 28, Issue 5
BROWSE ISSUES

Movement Disorders

October 2022, Vol.28, No.5

Guest Editor:

Kathleen L. Poston, MD, MS, FAAN

Editor-in-Chief:

STEVEN L. LEWIS, MD, FAAN

ISSN: 1080-2371

Online ISSN: 1538-6899

REVIEW ARTICLES
Prodromal α-Synucleinopathies
Chahine, Lana M.
CONTINUUM: Lifelong Learning in Neurology
October 2022 - Volume 28 - Issue 5, Movement Disorders - p 1268-1280
doi: 10.1212/CON.0000000000001153
Diagnosis and Medical Management of Parkinson Disease
Thaler, Avner; Alcalay, Roy N.
CONTINUUM: Lifelong Learning in Neurology
October 2022 - Volume 28 - Issue 5, Movement Disorders - p 1281-1300
doi: 10.1212/CON.0000000000001152
Surgical Therapies for Parkinson Disease
Rawls, Ashley E.
CONTINUUM: Lifelong Learning in Neurology
October 2022 - Volume 28 - Issue 5, Movement Disorders - p 1301-1313
doi: 10.1212/CON.0000000000001160
Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy Bodies
Weintraub, Daniel; Irwin, David
CONTINUUM: Lifelong Learning in Neurology
October 2022 - Volume 28 - Issue 5, Movement Disorders - p 1314-1332
doi: 10.1212/CON.0000000000001151
Diagnosis and Treatment of Essential Tremor
Wagle Shukla, Aparna
CONTINUUM: Lifelong Learning in Neurology
October 2022 - Volume 28 - Issue 5, Movement Disorders - p 1333-1349
doi: 10.1212/CON.0000000000001181
Multiple System Atrophy
Claassen, Daniel O.
CONTINUUM: Lifelong Learning in Neurology
October 2022 - Volume 28 - Issue 5, Movement Disorders - p 1350-1363
doi: 10.1212/CON.0000000000001154
Progressive Supranuclear Palsy and Corticobasal Syndrome
Pantelyat, Alexander
CONTINUUM: Lifelong Learning in Neurology
October 2022 - Volume 28 - Issue 5, Movement Disorders - p 1364-1378
doi: 10.1212/CON.0000000000001158
Chorea
Stimming, Erin Furr; Bega, Danny
CONTINUUM: Lifelong Learning in Neurology
October 2022 - Volume 28 - Issue 5, Movement Disorders - p 1379-1408
doi: 10.1212/CON.0000000000001169
Neurodegenerative Cerebellar Ataxia
Rosenthal, Liana S.
CONTINUUM: Lifelong Learning in Neurology
October 2022 - Volume 28 - Issue 5, Movement Disorders - p 1409-1434
doi: 10.1212/CON.0000000000001180
The Dystonias
Stephen, Christopher D.
CONTINUUM: Lifelong Learning in Neurology
October 2022 - Volume 28 - Issue 5, Movement Disorders - p 1435-1475
doi: 10.1212/CON.0000000000001159
Diagnosing Common Movement Disorders in Children
O’Malley, Jennifer A.
CONTINUUM: Lifelong Learning in Neurology
October 2022 - Volume 28 - Issue 5, Movement Disorders - p 1476-1519
doi: 10.1212/CON.0000000000001187
Palliative Care and Movement Disorders
Katz, Maya
CONTINUUM: Lifelong Learning in Neurology
October 2022 - Volume 28 - Issue 5, Movement Disorders - p 1520-1529
doi: 10.1212/CON.0000000000001162
Editor's Preface
Articles
Key Points
Abbreviations
Appendix
Issue Overview

List of Abbreviations

CONTINUUM: Lifelong Learning in Neurology October 2022 - Volume 28 - Issue 5, Movement Disorders -10.1212/01.CON.0000892532.15061.32 doi: 10.1212/01.CON.0000892532.15061.32

Movement Disorders

5-HT2A 5-Hydroxytryptamine, serotonin receptor 2A

AD Alzheimer disease

AES Apathy Evaluation Scale

AICA Anterior inferior cerebellar artery

AIDS Acquired immunodeficiency syndrome

AIMS Abnormal Involuntary Movement Scale

Anti-DNase B Anti-deoxyribonuclease B

AOA Ataxia with oculomotor apraxia

ASO Antistreptolysin O

ATP Adenosine triphosphate

ATPase Adenosine triphosphatase

BiPAP Bilevel positive airway pressure

CANVAS Cerebellar ataxia with neuropathy and vestibular areflexia syndrome

CAPOS Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss [syndrome]

CASPR2 Contactin-associated proteinlike 2

CBD Corticobasal degeneration

CBIT Comprehensive Behavioral Intervention for Tics

CBS Corticobasal syndrome

CBT Cognitive-behavioral therapy

COMT Catechol-O-methyltransferase

CPAP Continuous positive airway pressure

CSF Cerebrospinal fluid

CT Computed tomography

DBS Deep brain stimulation

DLB Dementia with Lewy bodies

DNA Deoxyribonucleic acid

DNAse Deoxyribonuclease

DRPLA Dentatorubral-pallidoluysian atrophy

DRS-2 Dementia Rating Scale–2

ECB Everyday Cognition Battery

EEG Electroencephalogram

EMG Electromyography

ET Essential tremor

FDA US Food and Drug Administration

FDG-PET Fludeoxyglucose positron emission tomography

FLAIR Fluid-attenuated inversion recovery

FTLD Frontotemporal lobar degeneration

FUS Focused ultrasound

FXTAS Fragile X tremor-ataxia syndrome

GABA γ-Aminobutyric acid

GABA-ergic γ-Aminobutyric acid–mediated

GAD Glutamic acid decarboxylase

GeM-HD Genetic Modifiers of Huntington’s Disease [Consortium]

GPi Globus pallidus internus

GRE Gradient recalled echo

HD Huntington disease

HDL Huntington disease–like

HIV Human immunodeficiency syndrome

IgG Immunoglobulin G

IM Intramuscular

IV Intravenous

IVIg Intravenous immunoglobulin

LARS Lille Apathy Rating Scale

LGI1 Leucine-rich glioma inactivated protein 1

MAO-B Monamine oxidase type B

MCI Mild cognitive impairment

MDS International Parkinson and Movement Disorder Society

MDS-NMS Movement Disorder Society–Nonmotor Symptoms

MIBG Metaiodobenzylguanidine

MoCA Montreal Cognitive Assessment

MRI Magnetic resonance imaging

MRIgFUS Magnetic resonance imaging–guided focused ultrasound

MS Multiple sclerosis

MSA Multiple system atrophy

MSA-C Multiple system atrophy with predominant cerebellar ataxia

MSA-P Multiple system atrophy with predominant parkinsonism

NBIA Neurodegeneration with brain iron accumulation

NfL Neurofilament light chain

NINDS-SPSP National Institute of Neurological Disorders and Stroke and Society for PSP

NMDAN-methyl-d-aspartate

NMSQ Nonmotor Symptom Questionnaire

NMSS Non-Motor Symptoms Scale

NPI Neuropsychiatric Inventory

PANDA Parkinson Neuropsychometric Dementia Assessment

PD Parkinson disease

PDAQ-15 Parkinson’s Daily Activities Questionnaire–15

PD-CFRS Parkinson Disease–Cognitive Functional Rating Scale

PD-CRS Parkinson Disease–Cognitive Rating Scale

PDD Parkinson disease dementia

PEG-J Percutaneous endoscopic gastrojejunostomy

PET Positron emission tomography

PICA Posterior inferior cerebellar artery

PKAN Pantothenate kinase–associated neurodegeneration

PPQ Parkinson Psychosis Questionnaire

PPRS Parkinson Psychosis Rating Scale

PSP Progressive supranuclear palsy

PSP-CBS Progressive supranuclear palsy with predominant corticobasal syndrome

PSP-F Progressive supranuclear palsy with predominant frontal presentation

PSP-OM Progressive supranuclear palsy with predominant ocular motor dysfunction

PSP-PGF Progressive supranuclear palsy with progressive gait freezing

PSP-P Progressive supranuclear palsy with predominant parkinsonism

PSP-PI Progressive supranuclear palsy with predominant postural instability

PSP-RS Progressive supranuclear palsy–Richardson syndrome

PSP-SL Progressive supranuclear palsy with predominant speech-language disorder

QSART Quantitative sudomotor axon reflex test

QSM Quantitative susceptibility imaging

QUIP-RS Questionnaire for Impulsive-Compulsive Disorders-Rating Scale

RBD Rapid eye movement sleep behavior disorder

REM Rapid eye movement

RT-QuIC Real-time quaking-induced conversion

SAPS-PD Scale for the Assessment of Positive Symptoms for Parkinson Disease

SCA Spinocerebellar ataxias

SCOPA-COG Scales for Outcomes of Parkinson Disease–Cognition

SLE Systemic lupus erythematosus

SNP Single-nucleotide polymorphism

SNRI Serotonin norepinephrine reuptake inhibitor

SPECT Single-photon emission computed tomography

SSRI Selective serotonin reuptake inhibitor

STN Subthalamic nucleus

tDCS Transcranial direct current stimulation

TMS Transcranial magnetic stimulation

TRH Thyroid-stimulating hormone (TSH)–releasing hormone

TSH Thyroid-stimulating hormone

UHDRS Unified Huntington’s Disease Rating Scale

UPDRS Unified Parkinson’s Disease Rating Scale

UPSA UCSD Performance-based Skills Assessment

VIM Ventralis intermedius

VMAT2 Vesicular monoamine transporter-2

© 2022 American Academy of Neurology.